Epperly Melissa B, bought ROIV

October 1, 2026 · Form 4 insider transaction

Epperly Melissa B, bought 17,750 shares of Roivant Sciences Ltd. at $4.46 per share, a transaction worth $79.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
17,750
Price
$4.46
Total value
$79.2K
RoleDirector
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateOctober 1, 2026
Filing dateOctober 5, 2026
Shares owned after32,704
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR